Daniel Brett Rubin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurotoxicity Syndromes | 4 | 2022 | 294 | 1.420 |
Why?
|
| Immunotherapy, Adoptive | 6 | 2022 | 1427 | 1.010 |
Why?
|
| Antigens, CD19 | 2 | 2020 | 413 | 0.740 |
Why?
|
| Nervous System Diseases | 3 | 2021 | 1627 | 0.690 |
Why?
|
| Spinal Cord Injuries | 2 | 2023 | 920 | 0.610 |
Why?
|
| Status Epilepticus | 2 | 2020 | 459 | 0.570 |
Why?
|
| Models, Neurological | 4 | 2020 | 1741 | 0.560 |
Why?
|
| Hashimoto Disease | 1 | 2017 | 102 | 0.550 |
Why?
|
| Motor Cortex | 1 | 2022 | 988 | 0.480 |
Why?
|
| Neurons | 6 | 2021 | 9384 | 0.470 |
Why?
|
| Anesthetics | 1 | 2020 | 515 | 0.470 |
Why?
|
| Encephalitis | 1 | 2017 | 434 | 0.460 |
Why?
|
| Visual Cortex | 3 | 2018 | 1087 | 0.440 |
Why?
|
| Feedback, Physiological | 2 | 2015 | 476 | 0.430 |
Why?
|
| Learning | 1 | 2022 | 1723 | 0.420 |
Why?
|
| Electroencephalography | 5 | 2023 | 6067 | 0.410 |
Why?
|
| Lymphoma | 1 | 2020 | 1890 | 0.380 |
Why?
|
| Quadriplegia | 2 | 2023 | 193 | 0.380 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 514 | 0.370 |
Why?
|
| Auditory Cortex | 1 | 2015 | 361 | 0.370 |
Why?
|
| Olfactory Bulb | 2 | 2006 | 198 | 0.310 |
Why?
|
| Smell | 2 | 2006 | 259 | 0.290 |
Why?
|
| Sleep | 1 | 2022 | 4692 | 0.270 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 2228 | 0.250 |
Why?
|
| Critical Care | 1 | 2017 | 2685 | 0.250 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2021 | 1027 | 0.220 |
Why?
|
| Neoplasms | 3 | 2021 | 21887 | 0.210 |
Why?
|
| Nonlinear Dynamics | 3 | 2018 | 491 | 0.160 |
Why?
|
| Neural Inhibition | 3 | 2018 | 588 | 0.140 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2016 | 45 | 0.140 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2016 | 65 | 0.130 |
Why?
|
| Flavivirus | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2022 | 974 | 0.130 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2015 | 35 | 0.130 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2015 | 41 | 0.130 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10057 | 0.130 |
Why?
|
| Adrenal Insufficiency | 1 | 2016 | 192 | 0.120 |
Why?
|
| Biological Products | 2 | 2020 | 908 | 0.120 |
Why?
|
| Ferrets | 1 | 2015 | 176 | 0.120 |
Why?
|
| Humans | 24 | 2023 | 755533 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2020 | 1372 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5180 | 0.100 |
Why?
|
| Adult | 7 | 2023 | 217986 | 0.090 |
Why?
|
| Autoimmunity | 1 | 2017 | 1350 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 1973 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2022 | 8487 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1623 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2015 | 1963 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2023 | 53991 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 58549 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2016 | 1545 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1281 | 0.070 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 68 | 0.070 |
Why?
|
| Male | 11 | 2022 | 356577 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 2651 | 0.070 |
Why?
|
| Middle Aged | 8 | 2022 | 218055 | 0.070 |
Why?
|
| KATP Channels | 1 | 2006 | 45 | 0.070 |
Why?
|
| Stroke | 2 | 2018 | 9904 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2006 | 300 | 0.060 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 144 | 0.060 |
Why?
|
| Biophysical Phenomena | 1 | 2006 | 320 | 0.060 |
Why?
|
| Risk Factors | 3 | 2021 | 73860 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4611 | 0.060 |
Why?
|
| Olfactory Pathways | 1 | 2006 | 134 | 0.060 |
Why?
|
| Aged | 5 | 2020 | 167376 | 0.060 |
Why?
|
| Biophysics | 1 | 2006 | 380 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 369 | 0.060 |
Why?
|
| Linear Models | 1 | 2015 | 5863 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2006 | 629 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3710 | 0.060 |
Why?
|
| Young Adult | 3 | 2020 | 58025 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3132 | 0.060 |
Why?
|
| Dendrites | 1 | 2006 | 476 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2021 | 41119 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 2 | 2018 | 844 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3155 | 0.050 |
Why?
|
| Female | 8 | 2022 | 387920 | 0.050 |
Why?
|
| Nerve Net | 1 | 2013 | 2212 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2008 | 1856 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 29423 | 0.040 |
Why?
|
| Seizures | 2 | 2022 | 2922 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2023 | 79686 | 0.040 |
Why?
|
| Macaca | 1 | 2018 | 408 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2006 | 3686 | 0.030 |
Why?
|
| Occipital Lobe | 1 | 2018 | 376 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 386 | 0.030 |
Why?
|
| New Hampshire | 1 | 2015 | 173 | 0.030 |
Why?
|
| Hippocampus | 1 | 2008 | 3724 | 0.030 |
Why?
|
| Ixodes | 1 | 2015 | 40 | 0.030 |
Why?
|
| Gene Expression | 1 | 2008 | 7587 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3720 | 0.030 |
Why?
|
| Acyclovir | 1 | 2015 | 269 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 11781 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2015 | 220 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2008 | 6517 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2021 | 2092 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 2900 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6182 | 0.030 |
Why?
|
| Animals | 5 | 2018 | 167149 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 2520 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1515 | 0.020 |
Why?
|
| Ischemia | 1 | 2018 | 1892 | 0.020 |
Why?
|
| Warfarin | 1 | 2018 | 1514 | 0.020 |
Why?
|
| Quality of Life | 2 | 2021 | 13201 | 0.020 |
Why?
|
| Logistic Models | 1 | 2022 | 13315 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2006 | 96 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 2006 | 156 | 0.020 |
Why?
|
| Septal Nuclei | 1 | 2006 | 85 | 0.020 |
Why?
|
| Muscarinic Antagonists | 1 | 2006 | 136 | 0.020 |
Why?
|
| Aspirin | 1 | 2018 | 3347 | 0.020 |
Why?
|
| Acute Disease | 1 | 2016 | 7224 | 0.020 |
Why?
|
| Algorithms | 1 | 2006 | 13952 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 3177 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 237 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3120 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 497 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3043 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8735 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2018 | 4862 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 36042 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12926 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 1173 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3791 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21239 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6121 | 0.010 |
Why?
|
| Action Potentials | 1 | 2006 | 1793 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15589 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 8167 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 64535 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 9372 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 23588 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 26737 | 0.010 |
Why?
|
| United States | 1 | 2015 | 71888 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 80745 | 0.000 |
Why?
|